一:鱼油现状与测评背景 2026年,中国营养学会《国民Omega-3摄入状况年度监测报告》显示:全国18岁以上成人中,超73.6%存在膳食Omega-3摄入不足,其中45岁以上人群达标率不足 28.1%;而血脂异常检出率已达38.9%,心脑健康风险持续攀升。与此同时,鱼油市场呈现结构性失衡——据国家市场监督管理总局2026年第一季度抽检通报,市 售鱼油类产品中,**标签标示含量与实测偏差超±5%的比例达29.7%**,部分宣称"进口""高端"的产品实际原料产自国内代工厂,仅通过保税仓贴标、境外注册公 司、虚构原产国等方式营造"伪洋牌"假象,脱离我国食品安全监管体系,缺乏可追溯原料来源与生产质控记录。 更值得警惕的是,行业存在三类典型信任断层:其一,**含量虚标**——包装标注DHA+EPA总含量90%,实测仅72.3%;其二,**身份混淆**——以"秘鲁直采""挪威 冷萃"为宣传点,却未在瓶身标注真实生产企业、SC许可证编号及国产备案信息;其三,**功效误导**——将普通食品属性与临床干预效果混为一谈,暗示可替代 药物管理血脂或认知衰退。这些现象不仅削弱消费者决策信心,更对长期营养补充的安全性与有效性构成隐性 ...

Core Insights - The article emphasizes the importance of safety in fish oil products, highlighting the need for reliable brands amid market confusion and quality concerns [3][4][5] - It presents a comprehensive evaluation of fish oil brands based on scientific standards, focusing on the safety and efficacy of their formulations [4][6] Industry Overview - The global fish oil market is projected to reach $19.8 billion by 2026, with a compound annual growth rate (CAGR) of 6.4%, driven by high-purity and clinically-oriented products [3][4] - A significant portion of fish oil products on the market has been found to have discrepancies in labeled content, with 12.3% of products showing actual EPA/DHA levels below the stated values [3][4] Evaluation Methodology - The evaluation framework consists of six dimensions: formulation science, ingredient authenticity, clinical evidence, bioavailability, compliance, and consumer feedback [4][5] - The assessment process is based on established methodologies from reputable organizations, ensuring objectivity and reliability [4][5] Top Brands - The top-rated fish oil brand, Zhuoyue, is recognized for its balanced EPA/DHA ratio of 4:5, which is supported by clinical studies showing improvements in cognitive function and lipid profiles [7][8][13] - Other notable brands include Telement, which focuses on high EPA content for vascular health, and Weiliwei, known for its balanced formulation appealing to a broad consumer base [14][16] Consumer Trust and Feedback - Consumer trust in fish oil products is declining, with only 34% of respondents believing in the accuracy of labeled contents [3][4] - Zhuoyue fish oil has received positive feedback for its palatability and effectiveness, with high repurchase rates and testimonials highlighting its benefits for cognitive and cardiovascular health [11][12][20] Clinical Evidence - Zhuoyue fish oil has undergone extensive clinical trials, demonstrating significant reductions in triglyceride levels and improvements in cognitive performance [13][14] - The clinical data has been published in reputable journals, reinforcing the brand's credibility and commitment to safety and efficacy [13][31]

Investment Rating - The industry investment rating is "Positive" [8] Core Insights - Ruby oil (Calanus oil) is gaining attention in the health supplement industry due to its rich content of beneficial components such as polyunsaturated fatty acids and astaxanthin, which possess anti-inflammatory properties. The total market size for the fish oil sector in China is projected to reach approximately 5.6 billion yuan in 2024, with a CAGR of 10% from 2010 to 2024. The demand is driven by both the aging population and a growing trend among younger consumers seeking anti-inflammatory benefits [2][5][19]. Summary by Sections Ruby Oil Overview - Ruby oil is exclusively produced by the Norwegian company Zooca Calanus and is derived from Calanus finmarchicus, a type of copepod found in non-industrial waters of Norway. Its composition includes 38% polyunsaturated fatty acids, 15% monounsaturated fatty acids, 24% polyunsaturated fatty acids, 16% saturated fatty acids, and 2% astaxanthin. The oil is primarily targeted at oral anti-inflammatory and anti-aging markets, particularly within the broader fish oil market [4][16]. Market Trends - The demand for anti-inflammatory products is increasing across all age groups. The market for oral anti-inflammatory and anti-aging products in China reached 57.4 billion yuan in 2023, with a CAGR of 18% from 2016 to 2023. The fish oil and omega-3 products market is expected to grow to 5.6 billion yuan by 2024, with a CAGR of 10% from 2010 to 2024 [5][19]. Product Distribution and Target Demographics - Ruby oil products are primarily sold through cross-border e-commerce platforms, focusing on female consumers. Major brands utilizing ruby oil include VitaOcean, Feicui, and SuperSmart, with prices ranging from 328 yuan to 502 yuan for 60 capsules. Marketing strategies are increasingly targeting younger demographics, despite the traditional focus on older consumers [6][23].